Apr 11, 2019
Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our Q1 2019 Report: Global Trends in Medtech Transactions applies the latest data to analyze current activities in the life sciences deal...
Apr 11, 2019
In this report you can find an overview and analysis of the following across the biopharma market in the US, Europe, and Asia (China and Japan). Key performance indicators for the life science market IPO and private financing activity and performance Deal activity...
Feb 4, 2019
Locust Walk is a global life sciences transaction firm. Our integrated team-based approach across capabilities, geographies, and industry segments delivers the right products, the right partners, and the most attractive sources of capital to get the right deals done...
Feb 4, 2019
Locust Walk is a global life science transaction firm. Our integrated team-based approach across capabilities, geographies, and industry segments delivers the right products, the right partners, and the most attractive sources of capital to get the right deals done...
Oct 18, 2018
Locust Walk is a global life science transaction firm. Our integrated team-based approach across capabilities, geographies, and industry segments delivers the right products, the right partners, and the most attractive sources of capital to get the right deals done...
Oct 18, 2018
Locust Walk is a global life science transaction firm. Our integrated team-based approach across capabilities, geographies, and industry segments delivers the right products, the right partners, and the most attractive sources of capital to get the right deals done...
